A Landscape of Artificial Intelligence (AI) In Pharmaceutical R&D

Where you find opportunities to grow

* Can't find your brand, product, service? Join BPT Marketplace

Big Data


[Interview] A New Way To Work With Data In Life Sciences

   by Andrii Buvailo    206
[Interview] A New Way To Work With Data In Life Sciences

Founded by renowned database researcher, Turing Award laureate MIT Professor Michael Stonebraker, Paradigm4 is not just any data analytics company in the Life Sciences. The organization is built on the decades of pioneering research in database design and possesses unique technological know-how in scientific data management and scalable computation. 

The firm has recently launched its REVEAL™: Single Cell app to offer biopharmaceutical developers the ability to break through the data wrangling and programming challenges associated with the analysis of large-scale, single-cell datasets. 

Aigenpulse launches data analysis suite to automate flow cytometry

   by Aigenpulse    476
Aigenpulse launches data analysis suite to automate flow cytometry

11th September 2020: Life science and data technology innovator, Aigenpulse, is launching its CytoML Experiment Suite – an automated, end-to-end, machine learning solution specifically aimed at streamlining and automating cytometry analysis at scale and replacing manual gating processes. With it, users will benefit from a single point-of-truth about all cytometry data across any organisation.

3 Ways Big Data and Machine Learning Revolutionize Drug Discovery

   by Andrii Buvailo    12871
3 Ways Big Data and Machine Learning Revolutionize Drug Discovery

The Internet media is trending now with numerous mentions of “big data”, “machine learning” and “artificial intelligence” all together destined to revolutionize pharmaceutical and biotech industries and the way drugs are discovered. These new technologies are believed to make drug discovery cheaper, faster, and more productive.

But how is “magic” supposed to happen, after all?